WallStreetZenWallStreetZen

NASDAQ: TLSI
Trisalus Life Sciences Inc Stock

$9.20-0.15 (-1.6%)
Updated Feb 23, 2024
TLSI Price
$9.20
Fair Value Price
$9.20
Market Cap
$242.11M
52 Week Low
$3.32
52 Week High
$16.24
P/E
-1.59x
P/B
28.53x
P/S
2.68x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.19M
Earnings
-$76.60M
Gross Margin
83%
Operating Margin
-304.86%
Profit Margin
-304.1%
Debt to Equity
2.95
Operating Cash Flow
-$72M
Beta
0.1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TLSI Overview

MedTech Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the healthcare sector in the U.S. MedTech Acquisition was incorporated in 2020 and is headquartered in Greenwich, CT.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TLSI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TLSI ($9.20) is undervalued by 0.04% relative to our estimate of its Fair Value price of $9.20 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TLSI ($9.20) is not significantly undervalued (0.04%) relative to our estimate of its Fair Value price of $9.20 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TLSI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TLSI due diligence checks available for Premium users.

Be the first to know about important TLSI news, forecast changes, insider trades & much more!

TLSI News

Valuation

TLSI fair value

Fair Value of TLSI stock based on Discounted Cash Flow (DCF)
Price
$9.20
Fair Value
$9.20
Undervalued by
0.04%
TLSI ($9.20) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TLSI ($9.20) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TLSI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TLSI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.59x
Industry
33.74x
Market
33.56x

TLSI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
28.53x
Industry
4.06x
TLSI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TLSI's financial health

Profit margin

Revenue
$5.2M
Net Income
-$1.3M
Profit Margin
-24.8%
TLSI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TLSI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$33.6M
Liabilities
$25.1M
Debt to equity
2.95
TLSI's short-term assets ($29.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TLSI's short-term assets ($29.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TLSI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$21.5M
Investing
-$1.3M
Financing
$40.3M
TLSI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TLSI vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
TLSI$242.11M-1.60%-1.59x28.53x
MASS$227.63M-1.13%-5.81x1.34x
ARAY$261.81M+1.15%-17.60x5.49x
SGHT$215.96M+3.02%-3.49x1.70x
CATX$269.35M+1.05%-9.60x2.73x

Trisalus Life Sciences Stock FAQ

What is Trisalus Life Sciences's quote symbol?

(NASDAQ: TLSI) Trisalus Life Sciences trades on the NASDAQ under the ticker symbol TLSI. Trisalus Life Sciences stock quotes can also be displayed as NASDAQ: TLSI.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.

What is the 52 week high and low for Trisalus Life Sciences (NASDAQ: TLSI)?

(NASDAQ: TLSI) Trisalus Life Sciences's 52-week high was $16.24, and its 52-week low was $3.32. It is currently -43.35% from its 52-week high and 177.11% from its 52-week low.

How much is Trisalus Life Sciences stock worth today?

(NASDAQ: TLSI) Trisalus Life Sciences currently has 26,316,681 outstanding shares. With Trisalus Life Sciences stock trading at $9.20 per share, the total value of Trisalus Life Sciences stock (market capitalization) is $242.11M.

Trisalus Life Sciences stock was originally listed at a price of $10.36 in Dec 18, 2020. If you had invested in Trisalus Life Sciences stock at $10.36, your return over the last 3 years would have been -11.2%, for an annualized return of -3.88% (not including any dividends or dividend reinvestments).

How much is Trisalus Life Sciences's stock price per share?

(NASDAQ: TLSI) Trisalus Life Sciences stock price per share is $9.20 today (as of Feb 23, 2024).

What is Trisalus Life Sciences's Market Cap?

(NASDAQ: TLSI) Trisalus Life Sciences's market cap is $242.11M, as of Feb 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Trisalus Life Sciences's market cap is calculated by multiplying TLSI's current stock price of $9.20 by TLSI's total outstanding shares of 26,316,681.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.